Skip to content

Ultrasonic scalpel vs. Monopolar electrocautery for d2 gastric carcinoma surgery: a multicenter randomized controlled trial

Ultrasonic scalpel vs. Monopolar electrocautery for d2 gastric carcinoma surgery: a multicenter randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004222
Enrollment
Unknown
Registered
2014-01-28
Start date
2014-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Ultrasonic scalpel Group:Use ultrasonic scalpel to coagulation and cut off blood vessel, separate and dissection lymph-nodes
some great vessels can ligation by nylon, silk line or Hemolock.
Monopolar electrocautery group:Use monopolar electrocautery to coagulation and cut off blood vessel, separate and dissection lymph-nodes

Sponsors

West China Hospital, Sichuan University, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Preoperative endoscopy and biopsy confirmed gastric adenocarcinoma, and predictively feasible of distal gastrectomy or total gastrectomy; 2. Predictively resectable diseases, either early or locally advanced gastric cancer, of preoperative staging JGCA 14th Edition cT1N0M0-T4aN3M0, I-IIIb, except T4b; 3. Aged 18 to 75 years; 4. Without serious disease; 5. Patients without previous history of upper abdominal surgery; 6. WHO performance score <2; 7. Male and female; 8. informed consent required.

Exclusion criteria

Exclusion criteria: 1. Patients with other severe comorbidities and cannot tolerate surgery: such as severe heart and lung diseases, heart function below clinical stage 2, uncontrollable hypertension, pulmonary infection, moderate to severe COPD, chronic bronchitis, severe diabetes and / or renal insufficiency, severe hepatitis and / or function below the rank of CHILD B grade, and severe malnutrition, etc.; 2. Patients treated with neoadjuvant chemotherapy or radiation therapy which might affect the efficacy observation; 3. Severity mental diseases; 4. Patients have joined in other Clinical trials and may have influence on the follow-up.

Design outcomes

Primary

MeasureTime frame
Intraoperative blood loss;Surgical duration;

Secondary

MeasureTime frame
Number of harvested lymph nodes;Intraoperative morbidity and mortality rates;Postoperative morbidity and mortality rate;

Countries

China

Contacts

Public ContactJian-Kun Hu

Department of Gastrointestinal Surgery, West China Hospital, Sichuan University

hujkwch@126.com+86 18980601504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026